| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 01/27/1999 | CN1041830C Peptide compound |
| 01/26/1999 | US5864021 Method and apparatus for the production of TGF-β and purified TGF-β compositions |
| 01/26/1999 | US5864012 Oligopeptides as antitumor agents |
| 01/26/1999 | US5864010 Enzyme inhibitor; antiinflammatory agent |
| 01/26/1999 | US5863957 Porous crosslinked polymeric microbeads having cavities joined by interconnecting pores wherein at least some of the cavities at the interior of each microbead communicate with the surface of the bead |
| 01/26/1999 | US5863937 Peptide conjugated compound as fungicides, bactericides, microbiocides treating candida albicans infection |
| 01/26/1999 | US5863890 Smooth muscle relaxants; anticoagulants; vasodilation; protein regulation; cellular metabolism; blood oxygen transport |
| 01/26/1999 | US5863804 Monoclonal or polyclonal antibodies obtained by administering to an animal a synthetic peptide or a recombinant protein fragment having a partial sequence of t-cadherin, isolating from animal's serum |
| 01/26/1999 | US5863708 Forming first and second passages each extending through dielectric substrate, forming plurality of channels on said first and second surfaces of dielectric substrate, forming a plurality of reservoirs; for conducting reactions in parallel |
| 01/26/1999 | CA1340353C Compositions and methods for removal of detergents |
| 01/26/1999 | CA1340329C Superoxide dismutasee |
| 01/21/1999 | WO1999002548A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
| 01/21/1999 | WO1999002185A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/20/1999 | EP0891985A1 Process for the production of biologically active protein (e.g. TGF) |
| 01/20/1999 | EP0891982A2 HIV peptides |
| 01/20/1999 | EP0792288B1 Conjugates of bdnf and nt-3 with a water-soluble polymer |
| 01/20/1999 | EP0668877B1 Displacement chromatography process and purified hemoglobin product |
| 01/19/1999 | US5862514 Method and means for synthesis-based simulation of chemicals having biological functions |
| 01/19/1999 | US5861491 Isolation of lactoferrin from milk |
| 01/19/1999 | US5861378 Polypeptides having specified amino acid sequences; antiseptics, effective against grampositive and gramnegative bacteria |
| 01/19/1999 | US5861377 Antistasin type serine protease inhibitors |
| 01/19/1999 | US5861351 Mixing a solvent, a carboxylic acid, a radical scavenger, and an organopalladium compound |
| 01/19/1999 | US5861150 Recombinant human CSF-1 dimer and compositions thereof |
| 01/19/1999 | US5861139 Method and composition for labeling proteins, peptides and amino acids, including antibodies, with a variety of metals ions (tin), including radioisotopes |
| 01/19/1999 | CA2081703C Thrombin and method of producing the same |
| 01/19/1999 | CA2025900C Derivative of tissue-type plasminogen activator |
| 01/14/1999 | WO1999001474A1 Methods for the isolation of proteinase inhibitor proteins from potato tubers |
| 01/14/1999 | WO1999001469A1 A method for attaching polyethylene glycol to macromolecules |
| 01/14/1999 | WO1999001409A1 Method for inferring protein functions with the use of ligand data base |
| 01/14/1999 | CA2687542A1 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
| 01/14/1999 | CA2294771A1 Method for inferring protein functions with the use of ligand data base |
| 01/14/1999 | CA2294613A1 Methods for the isolation of proteinase inhibitor proteins from potato tubers |
| 01/13/1999 | EP0890840A2 Assaying for collagen degradation in vivo |
| 01/13/1999 | EP0890640A2 G-CSF analog compositions and methods |
| 01/13/1999 | EP0890101A1 Selectively n-alkylated peptidomimetic combinatorial libraries and compounds therein |
| 01/13/1999 | EP0889966A1 Compositions and methods for producing heterologous polypeptides in pichia methanolica |
| 01/13/1999 | EP0889907A1 MONOCLONAL ANTIBODIES BINDING HUMAN GROWTH HORMONE (hGH) |
| 01/13/1999 | EP0889901A1 Process and intermediates for the synthesis of lhrh antagonists |
| 01/13/1999 | EP0847278A4 Analogs of parathyroid hormone |
| 01/13/1999 | CN1204651A Preparation method for spirulina polypeptide and medicament containing these polypeptide and application |
| 01/12/1999 | US5859282 Method of dissolving crystals of L-α-aspartyl-L-phenyl alanine methyl ester |
| 01/12/1999 | US5859219 Isolated nucleotide sequences used for detection of infection as primers for amplification and probes for hybridization; antiulcer agents; anticancer agents |
| 01/12/1999 | US5859193 Synthetic DNA derived recombinant HIV antigens |
| 01/12/1999 | US5859191 Method for the site-specific modification of peptide alpha amines |
| 01/12/1999 | US5859190 Solid phase synthesis to form a protected dipeptide followed by reacting with 1,1'-thiocarbonyldiimidazole to effect ring formation; efficiency; anticonvulsant,-arrhythmic and diabetic agents; herbicides and fungicides |
| 01/12/1999 | US5859188 Method for discovering novel anthelmintic compounds |
| 01/12/1999 | US5858804 Immunological assay conducted in a microlaboratory array |
| 01/12/1999 | US5858686 Methods for detecting tyrosine kinase-binding target proteins and identifying substances that affect SH2 phosphorylated ligand regulatory systems |
| 01/12/1999 | US5858670 Screening randomly synthesized oligopeptide- or oligonucleotide-solid phase libraries with acceptor molecules (e.g. antibodies), isolating solid phase support/oligomer bound to molecule, sequencing oligomer |
| 01/12/1999 | US5858188 Acrylic microchannels and their use in electrophoretic applications |
| 01/12/1999 | CA2153896C G-csf analog compositions and methods |
| 01/07/1999 | WO1999000422A1 Novel family of pheromone receptors |
| 01/07/1999 | EP0888591A1 Computational method for designing chemical structures having common functional characteristics |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |
| 01/07/1999 | EP0888386A1 Stable factor viii/ von willebrand factor complex |
| 01/07/1999 | EP0888382A1 Chromatographic process for obtaining very pure cyclosporin a and related cyclosporins |
| 01/07/1999 | EP0888157A1 Process for chromatographic separation of peptides and nucleic acid, and new high affinity ion exchange matrix |
| 01/07/1999 | EP0784632B1 Process for extracting high-purity von willebrand factor |
| 01/07/1999 | EP0672127B1 Use of thiol redox proteins for reducing disulfide bonds |
| 01/07/1999 | EP0528841B1 A method for the preparation of pyridoxylated hemoglobin |
| 01/07/1999 | CA2294473A1 Novel family of pheromone receptors |
| 01/06/1999 | CN1204344A Transferrin receptor protein of Moraxella |
| 01/06/1999 | CN1204342A Antineoplastic peptides |
| 01/05/1999 | US5856452 Oil bodies and associated proteins as affinity matrices |
| 01/05/1999 | US5856451 Conjugating a polypeptide with a polymer |
| 01/05/1999 | US5856447 Vaccine against lyme disease |
| 01/05/1999 | US5856440 Solid phase process for synthesizing thymosin α1 |
| 01/05/1999 | US5856297 Human C3b/C4b receptor (CR1) |
| 01/05/1999 | US5856296 DNA encoding interleukin-4 receptors |
| 01/05/1999 | US5856151 Antifungal preparations containing osmotin |
| 01/05/1999 | US5856142 Periplasmic expression enables recombinant proteins which are, in principle, correctly folded to be obtained directly in a space protected from the environment. |
| 01/05/1999 | US5856101 Dna sequences |
| 12/30/1998 | WO1998058961A1 Bactericidal/permeability-increasing protein: crystallization, x-ray diffraction, three-dimensional structure determination, rational drug design and molecular modeling of related proteins |
| 12/30/1998 | WO1998058949A1 Treatment of insulin resistance with growth hormone secretagogues |
| 12/30/1998 | WO1998058947A1 Dipeptide derivatives as growth hormone secretagogues |
| 12/30/1998 | WO1998058678A1 Anti-cd40l immunotoxins for the treatment of diseases |
| 12/30/1998 | EP0887417A2 Method of producing a 19P2 ligand by cleavage of a fusion protein containing it |
| 12/30/1998 | EP0887354A2 Process of working up of 1- N2-((S)-ethoxycarbonyl)-3-phenylpropyl)-N6-trifluor-acetyl -L-lysyl-L-prolin (Lisinopril(Tfa)ethylester, LPE) |
| 12/30/1998 | EP0886652A1 Pulmonary surfactant peptide solubilization process |
| 12/30/1998 | EP0886649A1 Protein occlusion for delivery of small molecules |
| 12/30/1998 | EP0705105A4 Metal chelates as spacer compounds in biologically active peptides |
| 12/30/1998 | EP0698038B1 Method of separating glycosylated and non-glycosylated proteins |
| 12/30/1998 | EP0686164B1 Intrinsic inhibitors of aldose reductase |
| 12/30/1998 | EP0661999B1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 12/30/1998 | CA2294464A1 Treatment of insulin resistance |
| 12/30/1998 | CA2293999A1 Bactericidal/permeability-increasing protein: crystallization, x-ray diffraction, three-dimensional structure determination, rational drug design and molecular modeling of relatedproteins |
| 12/29/1998 | US5854992 System and method for structure-based drug design that includes accurate prediction of binding free energy |
| 12/29/1998 | US5854404 Antitumor substance extracted from grifola |
| 12/29/1998 | US5854403 Method for isolation of highly pure von Willebrand Factor |
| 12/29/1998 | US5854397 Processs for cross-linking collagenous material |
| 12/29/1998 | US5854391 Glycosylation of peptides using glycosyl phosphite reagents |
| 12/29/1998 | US5854390 Chromatographic purification of vancomycin hydrochloride by use of preparative HPLC |
| 12/29/1998 | US5854389 Process for preparing modified proteins |
| 12/29/1998 | US5854387 Simple method for the purification of a bioelastic polymer |
| 12/29/1998 | US5853720 Combined process for the purification of vancomycin hydrochloride |
| 12/29/1998 | US5853668 Apparatus allowing sequential chemical reactions |
| 12/29/1998 | CA1340295C Human somatomedin carrier protein subunits and process for procucing them |
| 12/29/1998 | CA1340288C Generation and selection of novel binding proteins |
| 12/27/1998 | CA2242086A1 Method of producing a 19p2 ligand |
| 12/24/1998 | DE19827309A1 Tri:fluoro:acetyl lisinopril ethyl ester purification |